Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem

PloS One
Peter CollignonFahad Khan

Abstract

To determine how important governmental, social, and economic factors are in driving antibiotic resistance compared to the factors usually considered the main driving factors-antibiotic usage and levels of economic development. A retrospective multivariate analysis of the variation of antibiotic resistance in Europe in terms of human antibiotic usage, private health care expenditure, tertiary education, the level of economic advancement (per capita GDP), and quality of governance (corruption). The model was estimated using a panel data set involving 7 common human bloodstream isolates and covering 28 European countries for the period 1998-2010. Only 28% of the total variation in antibiotic resistance among countries is attributable to variation in antibiotic usage. If time effects are included the explanatory power increases to 33%. However when the control of corruption indicator is included as an additional variable, 63% of the total variation in antibiotic resistance is now explained by the regression. The complete multivariate regression only accomplishes an additional 7% in terms of goodness of fit, indicating that corruption is the main socioeconomic factor that explains antibiotic resistance. The income level of a countr...Continue Reading

References

Feb 4, 2003·Health Economics·Elamin H Elbasha
Apr 28, 2004·Emerging Infectious Diseases·Werner C AlbrichStephan Harbarth
Feb 15, 2005·Lancet·John Turnidge, Keryn Christiansen
Oct 14, 2008·Expert Review of Anti-infective Therapy·Frank M AarestrupPeter Collignon
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Jul 8, 2009·Applied and Environmental Microbiology·Chuanwu XiJerome Nriagu
Aug 19, 2009·The Journal of Antimicrobial Chemotherapy·Peter M Hawkey, Annie M Jones
Sep 14, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Kennedy, P Collignon
Apr 12, 2011·Lancet·Jean CarletAndreas Voss
May 11, 2011·Bulletin of the World Health Organization·Emily LeungUNKNOWN World Health Organization World Health Day Antimicrobial Resistance Technical Working Group
Jun 1, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rita L FinleyEdward Topp

❮ Previous
Next ❯

Citations

Mar 12, 2016·Journal of Pathogens·Ana Maria Gonzalez-Villoria, Veronica Valverde-Garduno
Aug 20, 2015·EBioMedicine·Glenn S Tillotson, Stephen H Zinner
Nov 14, 2015·Internal Medicine Journal·P Collignon
Nov 14, 2015·Public Health Ethics·Jasper Littmann, A M Viens
Jul 22, 2015·Pathogens and Global Health·Roberto Cauda, Antonio Cassone
Aug 9, 2016·BMC Medicine·Sze-Ann Woon, Dale Fisher
Jan 18, 2017·Health Policy·Björn Rönnerstrand, Victor Lapuente
Mar 18, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Chris Kenyon, Sheeba S Manoharan-Basil
Oct 21, 2016·Journal of Pharmaceutical Policy and Practice·Gemma L Buckland MerrettHayley MacGregor
Apr 11, 2018·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Esther-Maria Antão, Christian Wagner-Ahlfs
Dec 19, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Michael A Borg, Liberato Camilleri
Oct 28, 2019·International Journal of Hygiene and Environmental Health·Hani E J KabaSimone Scheithauer
Dec 2, 2019·Lancet·Patricia J García
Dec 30, 2020·Proceedings of the National Academy of Sciences of the United States of America·Rik OldenkampAntonio Cappuccio
Feb 17, 2021·Annual Review of Animal Biosciences·Noelle R NoyesRandall S Singer
Jul 1, 2021·JAC-antimicrobial Resistance·Peter Collignon, John J Beggs
Jul 6, 2021·American Journal of Clinical Pathology·Emily H GlynnTaryn Vian
Aug 28, 2021·Antibiotics·Xuemei ZhenCecilia Stålsby Lundborg
Jul 18, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J A CoxG Levy Hara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

© 2021 Meta ULC. All rights reserved